Document Detail


The effects of enalapril on urinary protein excretion in patients with idiopathic membranous nephropathy.
MedLine Citation:
PMID:  2312767     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
High doses of the angiotensin converting enzyme inhibitor, captopril, is known to cause significant increases in urinary protein excretion in patients with idiopathic membranous nephropathy. To find whether other angiotensin converting enzyme inhibitors yield similar results, we prospectively examined the effect of enalapril in five consecutive patients with idiopathic membranous nephropathy, elevated arterial pressure, and proteinuria and compared them to age-matched controls receiving clonidine. Glomerular filtration rate, 24-hour urinary protein excretion, and arterial pressure were measured. All patients served as their own controls. Those who received enalapril demonstrated an initial increase in proteinuria (-0.3 +/- 0.7 delta gm/day, clonidine vs 3.9 +/- 0.9 delta gm/day, enalapril: P less than .05) despite similar decreases in arterial pressure (-18 +/- 6 delta mm Hg, clonidine vs -22 +/- 6 delta mm Hg, enalapril: NS) and glomerular filtration rate (-1.1 +/- 0.8 delta mL/min, clonidine vs -1.9 +/- 1.2 delta mL/min, enalapril: NS) when compared to the clonidine group. This increase in proteinuria, however, did not occur when these patients were rechallenged with enalapril. To our knowledge, this is the first report to document a significant increase in preexisting nephrotic range proteinuria following administration of nonsulfhydryl ACE inhibitor. This increase, however, appears to be unique to the initial treatment phase of the disease and does not affect long-term management.
Authors:
E R Sauter; G L Bakris
Related Documents :
3902677 - A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of ...
6865647 - Yohimbine induced anxiety and increased noradrenergic function in humans: effects of di...
3426347 - Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardip...
632367 - Evaluation of intravenous clonidine in hypertensive emergencies.
6883417 - Global and regional function in the regionally ischaemic left ventricle related to plas...
17348427 - Cardiovascular reactivity of patients with essential and renal hypertension in an emoti...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  30     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-04-26     Completed Date:  1990-04-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  155-8     Citation Subset:  IM    
Affiliation:
Department of Medicine, Ochsner Clinic, New Orleans, LA 70121.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Clonidine / administration & dosage,  pharmacology*
Enalapril / administration & dosage,  pharmacology*
Female
Glomerulonephritis, Membranous / urine*
Humans
Hypertension / urine
Male
Middle Aged
Prospective Studies
Proteinuria / chemically induced*
Chemical
Reg. No./Substance:
4205-90-7/Clonidine; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Steady state pharmacokinetics of propranolol in Saudi Arabian patients and comparison with data for ...
Next Document:  Hemofiltrability of H2-receptor antagonist, famotidine, in renal failure patients.